All Industries

Top Oncology Companies

290 Oncology companies, sorted by total funding raised.

Jacobio PharmaIPO

China-based oncology drug discovery company developing induced allosteric inhibitors targeting th...

Beijing, China51–200Oncology, Drug Discovery
Series CTotal funding$55.0MAug 2018
Quanta Therapeutics

Biotechnology company developing precision therapies for RAS-driven cancers

United StatesBiotech, Healthcare
Series DTotal funding$50.0MMay 2023
Lucence

Precision oncology company committed to bringing clarity to cancer care and detection.

Singapore, SingaporeDiagnostics, Healthcare
Series BTotal funding$45.0MJan 2022
Asgard Therapeutics

Oncology (IO & targeted)

Lund, SwedenBiotech, Oncology
Series ATotal funding$39.7MMar 2024
Brenus Pharma

Cancer immunotherapy platform

Lyon, FranceBiotech, Oncology
Extension RoundTotal funding$37.6MJul 2026
Onc.AI, Inc.

Onc.AI is a digital health company that trains Onclara predictive AI models to improve oncology d...

San Carlos, United States11–50Biotech, Diagnostics
GrantTotal funding$34.7MAug 2025
PersonalisIPO

Genomic sequencing company enabling precision oncology and cancer biomarker discovery for biophar...

Menlo Park, United States201–500Genomics, Healthcare
Series CTotal funding$33.0MJan 2015
KarkinosAcquired

A purpose driven technology led oncology platform

IndiaHealthcare, Oncology
Series BTotal funding$32.9MMay 2022
Enara Bio

Developing therapies targeting Dark Antigens for cancer

Oxford, United Kingdom51–200Biotech, Oncology
Series BTotal funding$32.5MOct 2024
ATLAS ONCOLOGY PARTNERS

Enables value-based oncology care through embedded teams and risk-based models

Nashville, United StatesHealthcare, Oncology
Series ATotal funding$28.0MFeb 2026
Commit Biologics

Commit Biologics is a biotech spin-out from Aarhus University founded in 2021. The Commit team co...

Biotech, Drug Discovery
Extension RoundTotal funding$25.1MJan 2025
Beta Drugs

India's leading oncology focused pharmaceutical company

Panchkula, India51–200Biotech, Healthcare
Venture RoundTotal funding$25.0MNov 2024
ONCTERNAL THERAPEUTICS, INC.

R&D company with 3 SBIR/STTR awards from Department of Health and Human Services.

San Diego, United States11–50Biotech, Healthcare
GrantTotal funding$22.5MMar 2023
Mondego Bio

Developing best-in-class PTPN2 inhibitors to advance breakthrough cancer immunotherapies with imp...

Cantanhede, Portugal11–50Biotech, Oncology
Pre-seedTotal funding$22.3MSep 2025
4BaseCare

Personalized oncology care through advanced genomics

Singapore, Singapore201–500Biotech, Genomics
Series BTotal funding$21.4MJun 2026
BioSapien Inc.

Treating cancer locally

San Diego, United States1–10Biotech, Healthcare
Pre-seedTotal funding$19.6MJan 2025
BetaGlue Therapeutics

Pioneer in precision radiotherapy.

Milan, ItalyBiotech, Oncology
Corporate RoundTotal funding$18.7MDec 2024
One Biosciences

is a techbio company utilizing AI-driven single-cell technologies

FranceArtificial Intelligence, Biotech
Series ATotal funding$17.5MJul 2025
SAGA DiagnosticsAcquired

SAGA Diagnostics develops Pathlight, an ultra-sensitive blood-based multi-cancer test for early d...

Biotech, Genomics
Series ATotal funding$16.6MJun 2021
Abalos Therapeutics

Oncology (IO & targeted)

Düsseldorf, GermanyBiotech, Healthcare
Series ATotal funding$14.0MOct 2019
Signadori Bio

Signadori Bio is a preclinical stage biopharmaceutical company developing a next generation in vi...

Paris, France1–10Biotech, Oncology
SeedTotal funding$13.0MMay 2026
CIVATECH ONCOLOGY, INC.

R&D company with 5 SBIR/STTR awards from Department of Health and Human Services.

Morrisville, United States1–10Biotech, Life Sciences
GrantTotal funding$11.1MAug 2023
Lexent BioAcquired

Developed liquid biopsy platforms for cancer monitoring and genomic diagnostics.

San Francisco, United States11–50Biotech, Oncology
Venture RoundTotal funding$10.2M
Certis Oncology Solutions

Certis Oncology Solutions is an AI-enabled life science technology company based in San Diego, de...

San Diego, United StatesBiotech, Drug Discovery
Series CTotal funding$10.0MJan 2024
Alligator BioscienceIPO

Clinical-stage biotechnology company developing antibody-based tumor-directed immunotherapies for...

SwedenBiotech, Oncology
Venture RoundTotal funding$9.6MDec 2025